Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:35:22.279Z.
Calculation as of: 2026-10-06T15:35:22.279Z.
Quote observation: 2026-10-06T15:35:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f621ea2a381ac0066d385c57ed104ff22630177ee14cd635e65ed0429d7856c2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Aclaris Therapeutics, Inc.
Market Cap
$558.65M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$566.03M
Free Cash Flow Yield
44.21%
TTM Avg
19.72%
3Y Avg
17.48%
5Y Avg
17.48%
Market Cap
$560.00M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$567.12M
Free Cash Flow Yield
N/A
TTM Avg
3.48%
3Y Avg
3.86%
5Y Avg
13.58%
Market Cap
$555.16M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.08M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$576.52M
Free Cash Flow Yield
N/A
TTM Avg
7.20%
3Y Avg
7.20%
5Y Avg
7.20%
Market Cap
$538.58M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$540.95M
Free Cash Flow Yield
3.24%
TTM Avg
3.62%
3Y Avg
3.23%
5Y Avg
3.23%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | $558.65M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $566.03M | 44.21% | 19.72% | 17.48% | 17.48% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | N/A | 3.48% | 3.86% | 13.58% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $555.16M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $554.08M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | N/A | 7.20% | 7.20% | 7.20% |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $540.95M | 3.24% | 3.62% | 3.23% | 3.23% |
| OrthoPediatrics Corp. (KIDS)vs › | $586.76M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
